Cannabis Stock Destroyed by 81% Decline on Clinical Trial Failure

Intec Pharma Ltd. is a tiny company in the space of pot stocks, doing clinical research involving cannabis. But one of their drugs failed a Stage III clinical trial. Intec’s stock got crushed and lost 81 percent of its value. Intec Pharma said it was “disappointed” with the results of the study. | Source: Shutterstock […]

Continue Reading